Outside the Lab

 Outside the Lab Drug delivery

The Cost of Treating Cancer

| Roisin McGuigan

When you crunch the numbers on drug development, are the costs of cancer drugs justified?
Outside the Lab Diagnostics & prognostics

TRI a New Kind of Spectrometer

| Michael Schubert

An inexpensive, smartphone-based device could offer a wide range of point-of-care tests.
Outside the Lab Imaging

“May I Enjoy Life and Art”

| Ruth Steer

Research shows that art training can improve ophthalmologists’ observational skills.
Outside the Lab Public health

Tackling Old Age Before Birth

| Beth Curtis

Understanding the factors that influence epigenetic changes throughout life can help treat disease.
Outside the Lab Clinical trials

Too Pregnant to Participate

| Roisin McGuigan

Are current ethical guidelines for clinical studies letting pregnant women down?
Outside the Lab Neuroscience

Undoing the Damage

| Roisin McGuigan

Two drugs have shown potential to reverse brain damage in mice following alcohol exposure in the womb
Outside the Lab Personalized medicine

"Sexy" Needs Substance

| Rajesh Rao

We need to explain the context when using “grab bag” phrases in science and medicine

Outside the Lab Animal models

Pulling Back the Pre-Clinical Curtain

| William Aryitey

Are mouse models the best option we have?

Outside the Lab Clinical trials

Doing More with Less

| Raffaella Ravinetto

How can we best utilize equipment and resources in low-income regions?
Outside the Lab Public health

Change is Here, But Are We Ready For it?

| Giorgio Stanta

Patient-centric healthcare can only be fully achieved if we change the current organizational methods
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist